to remember how We were proudly discussing popularity of Dolo-650 mg When you and all others were taking this drug due to illness related to Covid-19?
Driven by a high fever, one of more common symptoms of Covid-19, sales of This white, oval-shaped pill has doubled and social media was immersed in water with Memes that claim to be the ‘best selling’ drug in India.
But time, as they say, changes.
Today, maker of Dolo-650 mg, Micro Labs, accused of Giving free gifts worth 1,000 crores for doctors to promote this anti-fever drug.
To be clear, Micro Labs is not officially to blame for bribery or corruption. They are only being investigated for Tax evasion.
However, the company facing reputation crisis with the allegations of Unethical Marketing Practices. Meanwhile, the National Medical Commission (NMC) medical organization is seeking details from the Income Tax Department of Doctors whose names were revealed during the drug company raids.
The move Doctors will discourage prescribing the brand anymore because they may not do so unnecessarily want To get the scanner or become a part of Argument.
In the latest move on Thursday, the Supreme Court raised concerns over Marketing practices by pharmaceutical companies specifically referred to the Dollo controversy.
The political isolation law was introduced by the lobby of Medical Representatives (Sales force of Federation of Pharmaceutical Companies of Medical Services and Sales Representatives Syndicate of India (FMRAI) alleged that Dolo maker provided free gifts to doctors.
In fact, Judge D.Y. Chandrachud, at the head benchHe described it as dangerous issue He said (as reported by Bar & Bench), “This is not music to my ears. I was also I asked to get the same when I had Covid. This is dangerous issue And the thing.”
Now, the center has been directed to submit a file reply within 10 days.
While the relationship between pharmaceutical companies and doctors is nothing new For discussion and there is no law or regulation to limit this, there are several loopholes that make this debate somewhat imperfect.
We Invited start Talk about those loopholes.
Rs 1,000 crore spent on Upgrade functional of Paracetamol!
Dolo-650 is an antipyretic pill manufactured using one of more commonand the oldest generic formulations known as paracetamol.
Paracetamol, a general salt, is a common used as analgesics treat aches and reduce high temperatures and was in The market since the sixties.
Crocin, Sumo, Dolo or Calpol – these are different names given by pharmaceutical companies that sell the same salt, paracetamol, under their copyright trademark. Hence, it is not an innovative patented complex drug made by Micro Labs.
to me add In addition, paracetamol is an essential drug and falls under government’s price Control mechanism, which means the company can not increase or fix The price of medicine above threshold decided it government.
The price that fixed by government for This category of Medicine is the same for All brands, no just for Dolo 650. The price for every tablet of Dolo-650 from Micro Lab, Cipla Paracip, Alkem’s Sumo and Glaxo SmithKline’s Calpol are the same – 2 rupees each tablet or bar of 15 tablets for 30 rupees.
Why Smart Pharma spend 1000 crore rupees on medicine under price control? What extra was he earning spend lavishly on marketing?
data more Chaos says the same story
They say, data never lies.
According to Micro Labs, the company generated revenue of 350 crores of sales of Dolo 650 in The last financial year Expires March 2022. Duration includes the trip of Dolo-650 given the formidable second A wave followed by a third wave of Covid-19 infection.
So did the company spend 1,000 crores to generate revenue of 350 crore rupees? This is it just bad or some more Gaps?
I spoke to three industry insiders who have worked or are working in senior levels in pharmaceutical companies. While it would be untrue, pretentious and confusing if you told them side of Stories and opinions over Controversy, they all estimated Micro Labs must have made a profit of Not more From 20-30 crore rupees on he won of 350 crores of sales of this medicine.
“This is a low margins class that lacks oomph. Possibility of The gain is very low. This category can only be used to create a brand name and restore value between clinicians and patients” official a job with big indian pharmaceutical maker, who he worked on preservative “Paracetamol” for more Over a decade, he tells me.
The economy is now even more anarchism. Does this mean that the company spent Rs 1,000 crore for just win of 30 crores?
In short: from grouprotation of Rs 4,000 crore, Micro Labs spent 25% or one fourth of The money on Marketing costs on just one The product and this product priceParacetamol controlled. In general, they offer over 400 products covering high-margin categories, including cardiology, diabetes, ophthalmology, dermatology, psychiatry, and more.
What is the figure of 1000 crore rupees?
Let’s understand how the number of Rs 1,000 crores has been calculated.
According to the widely read interview of Senior Official Dolo-650 on many of media Platforms, “Income tax investigators have collected total Marketing expenses of all departments of company for past several years arrive worth Rs 1,000 crore.”
Sources in The company and industry assured me that the estimate of Rs 1,000 crore includes marketing and promotional expenditures of Full Micro Labs for The last six Seven years. “then also, will not be equal to Rs 1,000 crores. He’s a strange character, God knows how It’s been calculated… Maybe some bits and pieces have been taken from here and there…” official Tell me related to the company.
Many industry officials believe that any drug with ‘Decent R&D expenditures’ will not require promotional expenditures of That kind, forget about selling paracetamol.
maybe we need more details on how A figure of Rs 1,000 crore has been calculated.
Dolo: old market leader
treatment or treatment protocol Issued by the Health Summit research bodyIndian Council of Medical Research (ICMR), the Ministry of Health and Family Welfare (MoHF & W), set forth in use of Paracetamol 650 mg instead of The more common 500 mg of The same medicine.
This was followed by an increase in the recipe of Dolo. But it wasn’t new fame. Dolo . remained market leader in 650 . class for over several years. company first Entering the 650 milligram (MG) category created the perception that it was more effective on fever due to unknown diseases.
On average, it starts in 2018, the brand acquired over 50 percent market share followed by Calpol, according to AIOCD-AWACS data. in fact in In 2010, Dolo-650 was awarded Best Managed Brand of The year. After that, it was recognized as the most admired brand in India followed by many other awards.
So there is no surprise rise in The business of Dolo-650 and according to Micro Labs, similar jump in Sales were observed even during Dengue and Chikungunya.
What was different this time was the internet frenzy And funny, clever, popular memes. So, this was the only one trigger behind Controversy or was there any other strong evidence?
essence…
it is not secret those companies spend money on Doctors and the unholy relationship exist. But, on On the other hand, if this matter of More important, then no willingness appeared before government to curb practice.
Despite requests from multiple lobbyists and NGOs, government he did not do made common code of Pharmaceutical Marketing Practices (UCPMP) is mandatory. This is guidance for pharmaceutical companies on What to do and what not to do while marketing products.
In this case, further investigation required To determine whether Micro Labs is entirely guilty, partly at fault, or no fault, but one The point is clear- it can not be just one A pharmaceutical company that bribes doctors or distributes free gifts.
Every other drug company is likely to be guilty and the entire ecosystem needs fixing. dilute hard issue by singles out Dolo is a maker bad luck!
Read the latest news And the Breaking news over here
